Daiichi seals Ranbaxy takeover
After countless examples of Indian companies acquiring their overseas rivals, drug manufacturer Ranbaxy is taking a different route, choosing instead to sell a controlling stake to Japan’s Daiichi Sankyo. How will the $4.6bn deal be financed? Read EuroWeek on Friday to find out.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: